Indian Council for Medical Research (ICMR, New Delhi)
Bare bones information on the vaccine (Bharat Biotech)
Trials
Pre-clinical (1) Immunogenecity and protective efficiency in hamsters iScience proof (pdf) (2) Immunogenecity and protective efficiency in rhesus macaques (preprint pdf)m (3) Safety immunogenecity (preprint bioRxiv)
Phase I Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine BBV152 (preprint medRxiv)
Salient features (Bharat Biotech)
Phase II Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report (preprint medRxiv)
Salient features (Bharat Biotech)
Phase III ONGOING
Vaccine drive Restricted use in emergency situation (Letter 3 Jan 2021)